Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer Reply

被引：0
|
作者：
Wang, Zhijie [1 ]
Zhao, Zhengyi [2 ]
Wang, Jie [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Clin Res Ctr Canc, Natl Canc Ctr,Canc Hosp,Dept Med Oncol, 17 Pan Jia Yuan South Ln, Beijing 100021, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
JAMA ONCOLOGY | 2020年 / 6卷 / 07期
关键词：
D O I：
10.1001/jamaoncol.2020.0646
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1116 / +
页数：2
相关论文
共 50 条
  • [1] Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer
    Ghiorghiu, Serban
    Mukhopadhyay, Pralay
    Massacesi, Cristian
    [J]. JAMA ONCOLOGY, 2020, 6 (07) : 1115 - 1116
  • [2] Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer A Systematic Review and Meta-analysis
    Duan, Jianchun
    Cui, Longgang
    Zhao, Xiaochen
    Bai, Hua
    Cai, Shangli
    Wang, Guoqiang
    Zhao, Zhengyi
    Zhao, Jing
    Chen, Shiqing
    Song, Jia
    Qi, Chuang
    Wang, Qing
    Huang, Mengli
    Zhang, Yuzi
    Huang, Depei
    Bai, Yuezong
    Sun, Feng
    Lee, J. Jack
    Wang, Zhijie
    Wang, Jie
    [J]. JAMA ONCOLOGY, 2020, 6 (03) : 375 - 384
  • [3] Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
    Pezeshki, Parmida Sadat
    Mahdavi Sharif, Pouya
    Rezaei, Nima
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (12) : 1575 - 1590
  • [4] Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin Lymphoma
    Villasboas, Jose Caetano
    Ansell, Stephen
    [J]. CANCER JOURNAL, 2016, 22 (01): : 17 - 22
  • [5] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
    Wang, Tianyu
    Wu, Xiaoxing
    Guo, Changying
    Zhang, Kuojun
    Xu, Jinyi
    Li, Zheng
    Jiang, Sheng
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) : 1715 - 1730
  • [6] Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
    Zhao, Jing
    Huang, Jian
    [J]. CHINESE MEDICAL JOURNAL, 2020, 133 (07) : 853 - 862
  • [7] Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
    Zhao Jing
    Huang Jian
    [J]. 中华医学杂志(英文版), 2020, 133 (07) : 853 - 862
  • [8] Expression of programmed cell death ligand 1 and programmed cell death 1 in cutaneous warts
    Yu, Wesley Y.
    Berger, Timothy G.
    North, Jeffrey P.
    Laszik, Zoltan
    Cohen, Jarish N.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (05) : 1127 - 1133
  • [9] New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    [J]. CANCER JOURNAL, 2017, 23 (01): : 10 - 22
  • [10] Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action
    Zhang, Ni
    Tu, Jingyao
    Wang, Xue
    Chu, Qian
    [J]. IMMUNOTHERAPY, 2019, 11 (05) : 429 - 441
12345